Azithromycin alters spatial and temporal dynamics of airway microbiota in idiopathic pulmonary fibrosis

BACKGROUND: High bacterial burden in the lung microbiota predicts progression of idiopathic pulmonary fibrosis (IPF). Azithromycin (AZT) is a macrolide antibiotic known to alter the lung microbiota in several chronic pulmonary diseases, and observational studies have shown a positive effect of AZT o...

Descripción completa

Detalles Bibliográficos
Autores principales: Gijs, Pieter-Jan, Daccord, Cécile, Bernasconi, Eric, Brutsche, Martin, Clarenbach, Christian F., Hostettler, Katrin, Guler, Sabina A., Mercier, Louis, Ubags, Niki, Funke-Chambour, Manuela, von Garnier, Christophe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2023
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10204823/
https://www.ncbi.nlm.nih.gov/pubmed/37228285
http://dx.doi.org/10.1183/23120541.00720-2022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10204823/
https://www.ncbi.nlm.nih.gov/pubmed/37228285
http://dx.doi.org/10.1183/23120541.00720-2022

Ejemplares similares